InspireMD Historical Income Statement
| NSPR Stock | USD 3.00 0.02 0.67% |
Historical analysis of InspireMD income statement accounts such as Total Operating Expenses of 14.4 M can show how well InspireMD performed in making a profits. Evaluating InspireMD income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of InspireMD's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining InspireMD latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InspireMD is a good buy for the upcoming year.
InspireMD |
About InspireMD Income Statement Analysis
InspireMD Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to InspireMD shareholders. The income statement also shows InspireMD investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
InspireMD Income Statement Chart
Add Fundamental
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Most accounts from InspireMD's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Income Tax Expense is relatively stable compared to the past year. As of 12/23/2024, Total Other Income Expense Net is likely to grow to about 1.4 M, while Selling General Administrative is likely to drop slightly above 8 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 3.7M | 4.1M | 4.4M | 3.1M | Research Development | 5.2M | 7.8M | 8.0M | 4.3M |
InspireMD income statement Correlations
Click cells to compare fundamentals
InspireMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InspireMD income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 42K | 160K | 157K | 28K | 25.2K | 23.9K | |
| Selling General Administrative | 5.2M | 6.1M | 7.4M | 8.4M | 11.1M | 8.0M | |
| Other Operating Expenses | 13.5M | 12.9M | 19.2M | 23.9M | 27.3M | 16.1M | |
| Operating Income | (9.8M) | (10.4M) | (14.7M) | (18.7M) | (21.1M) | (20.1M) | |
| Ebit | (9.8M) | (10.4M) | (14.7M) | (18.7M) | (21.1M) | (20.1M) | |
| Ebitda | (9.7M) | (10.2M) | (14.6M) | (18.5M) | (20.9M) | (19.9M) | |
| Total Operating Expenses | 10.6M | 10.5M | 15.5M | 19.8M | 23.0M | 14.4M | |
| Income Before Tax | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (20.8M) | |
| Net Income | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (20.9M) | |
| Total Other Income Expense Net | (200K) | (160K) | (157K) | 250K | 1.3M | 1.4M | |
| Depreciation And Amortization | 158K | 151K | 161K | 188K | 232K | 182.6K | |
| Total Revenue | 3.7M | 2.5M | 4.5M | 5.2M | 6.2M | 3.3M | |
| Gross Profit | 756K | 83K | 754K | 1.1M | 1.8M | 1.0M | |
| Research Development | 3.0M | 2.2M | 5.2M | 7.8M | 8.0M | 4.3M | |
| Cost Of Revenue | 3.0M | 2.4M | 3.7M | 4.1M | 4.4M | 3.1M | |
| Selling And Marketing Expenses | 2.4M | 2.1M | 2.9M | 3.7M | 3.9M | 3.3M | |
| Net Income From Continuing Ops | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (19.9M) | (20.9M) | |
| Net Income Applicable To Common Shares | (10.0M) | (10.5M) | (14.9M) | (18.5M) | (21.3M) | (22.3M) | |
| Net Interest Income | (200K) | (160K) | (157K) | 250K | 1.3M | 1.4M | |
| Reconciled Depreciation | 158K | 151K | 161K | 188K | 232K | 191.7K |
Pair Trading with InspireMD
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.Moving together with InspireMD Stock
Moving against InspireMD Stock
| 0.63 | ENSG | Ensign Group | PairCorr |
| 0.62 | DRIO | DarioHealth Corp | PairCorr |
| 0.6 | EDAP | EDAP TMS SA | PairCorr |
| 0.49 | VTAK | Catheter Precision | PairCorr |
| 0.49 | EKSO | Ekso Bionics Holdings | PairCorr |
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for InspireMD Stock Analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.